We are live on
!
Find out more
EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
32 hedge funds and large institutions have $4.3M invested in ESSA Pharma in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
126% more call options, than puts
Call options by funds: $165K | Put options by funds: $73K
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
11% less funds holding
Funds holding: 36 → 32 (-4)
22.17% less ownership
Funds ownership: 69.77% → 47.61% (-22%)
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
92% less capital invested
Capital invested by funds: $52.7M → $4.3M (-$48.3M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
32
Holders Change
-4
Holders Change %
-11.11%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
8
Reduced
8
Closed
12
Calls
$165K
Puts
$73K
Net Calls
+$92K
Net Calls Change
-$880K
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$3.5M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$2.52M |
| 3 |
SC
Shay Capital
New York
|
+$614K |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
+$409K |
| 5 |
Two Sigma Investments
New York
|
+$136K |
Top Sellers
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$7.31M |
| 2 |
BCM
BML Capital Management
Zionsville,
Indiana
|
-$7.18M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$3.76M |
| 4 |
Morgan Stanley
New York
|
-$2.76M |
| 5 |
AC
Aldebaran Capital
Carmel,
Indiana
|
-$984K |
